Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies - Takeaways - MDSpire

Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies

  • By

  • Jaime Francisco Larre-Guerra

  • Álvaro Castrillo-Capilla

  • Macarena Garbayo-Bugeda

  • Andrea Kallmeyer

  • Ester Cánovas

  • María Nieves Tarín

  • Carmen Cristóbal

  • Ana Huelmos

  • Carlos Gutiérrez-Landaluce

  • José Antonio Esteban Chapel

  • Junior Senra

  • María Luisa González Casaus

  • Joaquín Alonso

  • Lorenzo López-Bescós

  • Ignacio Mahíllo

  • Óscar Lorenzo

  • José Manuel Rubio-Campal

  • José Tuñón

  • April 20, 2026

  • 0 min

Share

  • 1

    Atrial fibrillation (AF) is a prevalent arrhythmia with increasing incidence and significant clinical implications.

  • 2

    Mineral metabolism, particularly FGF23, is linked to cardiovascular disease and may predict AF after acute coronary syndrome (ACS).

  • 3

    The study analyzed 1257 patients from the BACS and BAMI studies, focusing on AF development post-ACS.

  • 4

    Demographic, clinical variables, and blood samples were collected to assess predictors of AF in different age groups.

  • 5

    The primary outcome measured was the development or recurrence of AF, confirmed through systematic ECG reviews.

Original Source(s)

Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies

  • by Jaime Francisco Larre-Guerra, Álvaro Castrillo-Capilla, Macarena Garbayo-Bugeda, Andrea Kallmeyer, Ester Cánovas, María Nieves Tarín, Carmen Cristóbal, Ana Huelmos, Carlos Gutiérrez-Landaluce, José Antonio Esteban Chapel, Junior Senra, María Luisa González Casaus, Joaquín Alonso, Lorenzo López-Bescós, Ignacio Mahíllo, Óscar Lorenzo, José Manuel Rubio-Campal, José Tuñón

  • April 20, 2026

Related Content

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.